Fagrell B, Arver S, Intaglietta M, Tsai A G
Institutionen för Medicin, Karolinska Sjukhuset, Stockholm, Sweden.
J Intern Med. 1989 Apr;225(4):257-60. doi: 10.1111/j.1365-2796.1989.tb00075.x.
Marked circadian variations in the activated partial thromboplastin time (APTt) during continuous heparin infusions for thromboembolic episodes have been reported in a French study. The aim of the present study was to test if these variations could be reproduced in a Swedish population. The frequency spectrum variations in APTt values were analysed with the Prony and the statistical Pearson product momentum correlation coefficient methods. In seven patients with pulmonary embolism, APTt was checked every fourth hour during 48 h of continuous, constant heparin treatment. In only one patient was a distinct circadian variation of APTt values seen. In six patients with venous leg thromboses, treated with s.c. heparin, marked variations in APTt were noticed over periods of 12 h. These variations paralleled the regular s.c. injections of heparin every twelfth hour. The results of the present study could not confirm the marked circadian variations in APTt reported in an earlier French study during continuous heparin infusions, except in one patient.
法国一项研究报告称,在持续输注肝素治疗血栓栓塞发作期间,活化部分凝血活酶时间(APTt)存在明显的昼夜变化。本研究的目的是检验这些变化是否能在瑞典人群中重现。采用普罗尼方法和统计皮尔逊积矩相关系数方法分析了APTt值的频谱变化。在7例肺栓塞患者中,在持续、恒定肝素治疗48小时期间,每4小时检查一次APTt。仅1例患者出现了明显的APTt值昼夜变化。在6例接受皮下肝素治疗的下肢静脉血栓形成患者中,在12小时内观察到APTt有明显变化。这些变化与每12小时定期皮下注射肝素相平行。本研究结果无法证实先前法国研究报告的持续输注肝素期间APTt存在明显的昼夜变化,仅有1例患者除外。